Cita APA

Spelman, T., Herring, W. L., Acosta, C., Hyde, R., Jokubaitis, V., Pucci, E., . . . Butzkueven, H. (2024). Comparative effectiveness and cost-effectiveness of natalizumab and fingolimod in rapidly evolving severe relapsing-remitting multiple sclerosis in the United Kingdom.

Citación estilo Chicago

Spelman, Tim|||0000-0001-9204-3216, et al. Comparative Effectiveness and Cost-effectiveness of Natalizumab and Fingolimod in Rapidly Evolving Severe Relapsing-remitting Multiple Sclerosis in the United Kingdom. 2024.

Cita MLA

Spelman, Tim|||0000-0001-9204-3216, et al. Comparative Effectiveness and Cost-effectiveness of Natalizumab and Fingolimod in Rapidly Evolving Severe Relapsing-remitting Multiple Sclerosis in the United Kingdom. 2024.